3 Top Small-Cap Stocks to Buy Right Now
These three small-cap stocks have outstanding growth potential.
Regenxbio
RGNX
$54.65
-$0.07
-0.1%
BATS BZX Real Time Price as of April 18, 2019, 4:30 p.m.
View Interactive RGNX Charts
REGENXBIO INC COM USD0.0001
News & Analysis: Regenxbio
All
Market Moves
Earnings
Regenxbio Inc. (RGNX) Q4 2018 Earnings Conference Call Transcript
RGNX earnings call for the period ending December 31, 2018.
Here's Why Gene Therapy Stocks Are Soaring Today
Roche acquired Spark Therapeutics for a cool $4.8 billion, which sent peers soaring.
Gene Therapy Could Be a Boon for This Biotech
A small biotech is on the cusp of a big market opportunity.
Better Know Biotech: Regenxbio Inc.
This gene therapy company has big catalysts approaching that could cause shares to pop or drop.
3 Best Gene Therapy Stocks of 2018 (So Far)
These gene therapy stocks have generated huge returns so far this year. But can they keep up their winning ways?
What Happened in the Stock Market Today
On a day the market benchmarks closed up, Novartis announced it's buying AveXis and Leucadia National detailed plans to divest some assets and rename itself.
Here's Why Regenxbio Dropped as Much as 17.6% Today
The biopharma darling provided a year-end 2017 corporate update. Wall Street wasn't impressed.
